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In previous studies, we and others have demonstrated that the enzyme terminal 
deoxynucleotidyl transferase (TdT) a normally is restricted to primitive lymphoid 
cells, most certainly of the T  cell series and possibly of the B cell series as well 
(reviewed in  1-3). Our studies have also suggested that TdT + bone marrow cells 
or their  immediate precursors (pre-TdT + cells) may serve as the transformable 
target  cells  for  the  Gross  leukemia  virus  (4),  and  that  abnormalities  in  the 
development of TdT + bone marrow cells and thymocytes are among the earliest 
lymphoid defects to occur in mutant strains of autoimmune NZB/W, BXSB, and 
SJL/J mice. 2 Other  authors  (5-7) have postulated that  TdT  may itself play an 
important  role in the antigen-independent  development of lymphocytes, either 
in  the generation  of immunological  diversity and/or  in  the elimination  of self- 
reactive clones of immature  lymphocytes. Thus,  it is likely that  further  studies 
of TdT + bone marrow cells would provide valuable information concerning the 
early stages of normal and abnormal lymphocyte development. 
Progress in  the study of the  development and differentiation  of TdT + cells, 
and  of the  antigen-independent  phase  of lymphopoiesis  generally,  has  been 
hampered by the absence of a  selective in  vitro system for culturing  lymphoid 
stem  and  progenitor  cells.  Earlier  (8),  we  demonstrated  that  small  numbers 
(~2%) of mouse TdT + bone marrow cells could be generated in modified Dexter- 
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type cultures for at least 7 wk. Such cultures also contained colony-forming unit- 
spleen (CFU-S) and myeloid and erythroid progenitor cells. In the present study, 
we describe a primary xenogeneic culture system in which rat TdT + bone marrow 
cells are selectively generated on feeder layers of mouse bone marrow cells under 
conditions that do not support the survival of CFU-S or nonlymphoid progenitor 
cells. The cultured TdT + bone marrow cells do not cause leukemia, are indistin- 
guishable  phenotypically  from  their  normal  counterparts  in  vivo,  and  can  be 
generated with equal facility from the bone marrow of normal and congenitally 
athymic (nu/nu)  rats. 
Materials and  Methods 
Animals 
3-5-wk-old male (Lewis x  DA)F1 (LDA F1) rats and (C57BL/6J ×  A/Thy-l.1)F~ (B6A 
F~)  mice  from  our  breeding  colonies  were  used  in  most  of the  experiments.  Other 
experimental animals used in some experiments included:  F344,  Buffalo (BUF), Albany 
(ALB),  M520,  and  NIH-rnu (nu/nu and nu/+) strain rats; and C57BL/6J,  C57BL/10, 
A/J, DBA/2J, NZW, and NZB strain mice. 
Culture Medium, Hormones, and Growth Factors 
RPMI  1640  (Flow Laboratories, McLean, VA) contained 0.015  M Hepes buffer and 
50 #g/ml gentamycin sulfate (Schering Co., Kenilworth, NJ). 
Aliquots of ~500  ml of fetal bovine serum (FBS) (Gibco Laboratories, Grand Island, 
NY) were mixed with  1 mg/mi dextran (average mol wt, 40,000) and 10 mg/ml Norit A 
activated charcoal (Sigma Chemical Co., St.  Louis, MO) in a gyratory water bath shaker 
for 30 min at 56 o  C. The activated charcoal was removed by centrifugation (12,000 g for 
10 min) at 4°C and the charcoal-extracted FBS (ChXFBS) was sterilized by membrane 
filtration. This treatment has been shown to remove >90% of the steroid hormones and 
~30% of the thyroid hormone, but <2% of the total protein from serum (9). Additionally, 
defined FBS (HyClone) was purchased from Sterile Systems, Inc., Logan, UT. This FBS 
had very low levels of endotoxin and steroid hormones, obviating the need for charcoal 
extraction. All of the above sera were stored at -70°C until immediately before use. 
Fibroblast  growth  factor  (FGF)  (Collaborative  Research  Inc.,  Waltham,  MA)  was 
reconstituted  in  phosphate-buffered  saline  (PBS)  at  a  stock  concentration  1,000-fold 
higher than  the final concentration and was stored at -70°C.  Hydrocortisone, prosta- 
glandin  E~  (PGE~),  estradiol-17/3,  progesterone,  aldosterone,  and  testosterone  (Sigma 
Chemical Co.), and dexamethasone (Organon,  Inc., W.  Orange,  NJ) were dissolved in 
95% ethanol at a concentration of 1 ×  10 -2 M and were stored at -20°C. 
Bone marrow extracts (BMX) were prepared by sonicating (Biosonik: Bronwill Scien- 
tific, Rochester,  NY) plugs of femoral bone marrow in cold PBS at a  ratio of 1:3.  The 
sonicates were centrifuged (480 g  for  15  min) at 4°C  to remove tissue fragments, and 
then centrifuged at 25,000 g for 20 rain at 4°C. The supernatants were sterilized using 
an 0.2-t~m  filter unit  (Nalge Co.,  Nalgene Labware Div.,  Rochester,  NY).  The protein 
contents of the  supernatants  were measured by the Coomassie Blue colorimetric assay 
(10). 
Preparation of Feeder Layers 
Bone marrow cells from the femur and tibia of 6-12 animals were aseptically collected 
into a  sterile centrifuge tube by perfusing the shaft with culture medium. A  single-cell 
suspension was made by repetitive pipetting. ~ 1 ×  107 nucleated cells in 2 ml RPMI 1640 
supplemented with  10% FBS were placed in 35-mm diameter, flat-bottom plastic culture 
dishes (Costar, Cambridge, MA) and incubated at 37°C in 5% CO2 in air. The medium 
was changed on day 7.  By day 10 the culture wells contained confluent layers of tightly 
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Spleen and thymus were minced finely with sterile scalpels in RPMI 1640 supplemented 
with 10% FBS. The organ fragments were washed in the medium and cultured in 60-mm 
diameter plastic tissue culture dishes (Corning Glass Works, Corning, NY). The culture 
medium was changed once a week until a confluent adherent layer was obtained. 
Culture of Bone Marrow Cells 
Nonadherent cells  were removed from the confluent feeder layers by washing with 
fresh medium. The cultures, prepared in triplicate, were then charged with single-cell 
suspensions of bone marrow (1  x  103 to 1 x  106 cells/ml) in RPMI  1640 supplemented 
with30% defined, undefined, or ChXFBS. 
Antisera 
The following mouse anti-rat monoclonal antibodies were purchased: W3/13 (pan-T 
cell),  W3/25 (helper/inducer T  cell),  OX3 (Ia, polymorphic), OX4 (Ia, common deter- 
minant),  OX8  (suppressor/cytotoxic T  cell),  and  OX19  (pan-T  cell)  (11)  (Accurate 
Chemical and Scientific Corp., Westbury, NY); Thy-1.1 (New England Nuclear, Boston, 
MA).  Rat monoclonal antibodies to the rat RT-7  ~ (A.  R. T.-1 a) pan-T cell ailoantigen, 
the RT-6  a (A. R. T.-2  a) peripheral T cell alloantigen, and the A. R. T.-3 (CS 1.21) cortical 
thymocyte alloantigen were produced as previously described (12). Alloantiserum to the 
RT-1 rat major histocompatibility antigen was prepared by immunizing Lewis strain rats 
with lymph node and spleen cells from DA strain rats (13).  After absorption with LEW 
rat erythrocytes and B6A F~ mouse spleen cells, the antiserum reacted with LDA F~ rat 
bone marrow cells but not with B6A Ft mouse bone marrow cells. Alloantiserum to the 
H-2 mouse major histocompatibility antigen (H-2  b) was  a  kind gift from Dr.  Herbert 
Freedman (State University of New York, Downstate Medical Center, Brooklyn). Affinity 
column-purified IgG F(ab')~  rabbit antibodies to homogeneous calf TdT was obtained 
from Dr.  F.  Bollum (Uniformed Services University of the Health Sciences, Bethesda, 
MD)  (14,  15).  Fluorescein  isothiocyanate  (FITC)-goat  IgG  F(ab'),  anti-mouse  IgG, 
TRITC-goat IgG F(ab')2 anti-mouse IgG, TRITC-goat IgG F(ab')2 anti-rat IgG, FITC- 
goat IgG F(ab')~ anti-rabbit IgG, and goat IgG anti-rat IgM were purchased from Cappei 
Laboratories (Cochranville, PA). 
Iramunofluorescence 
Cell surface antigens.  ~ 1.5 × 106 nucleated cells were washed in RPMI 1640 containing 
20 mM sodium azide, incubated in suspension with the primary antiserum for 15 min at 
4 ° C, washed, and developed for immunofluorescence with TRITC- or FITC-conjugated 
goat IgG  F(ab')~  against  the primary antiserum.  The percentage of positive cells  was 
determined by fluorescence microscopy. 
TdT.  ~1.2 x  l0  s nucleated cells were smeared onto glass slides with a cytocentrifuge 
(Shandon Southern Instruments, Inc., Sewickley, PA), air dried, and fixed in cold absolute 
methanol for 15 min at 4°C. The smears were then incubated with 10 ~l of rabbit anti- 
calf TdT (30 #g/ml) for 15 min at room temperature, washed, and developed with FITC- 
goat IgG F(ab')2 anti-rabbit IgG (15).  Double immunofluorescence for surface antigens 
and TdT was performed by staining viable cells in suspension before smearing and fixing 
the cells (16). 
Cell Separation  and Analysis on the Fluorescence-activated  Cell Sorter (FACS) 
Cells were analyzed and sorted on the FACS (FACS IV; B-D FACS Systems, Sunnyvale, 
CA) according to their relative low angle light scatter (1.5-15 °) and relative fluorescence 
intensity for surface antigens as described previously (17). 
CFU-S Assay 
The in vivo CFU-S assay for pluripotent hematopoietic stern cells (18) was performed 
in irradiated (750 rad) 4-6-wk-old LDA Ft strain rats as described previously (17).  1 × 
106 freshly harvested rat bone marrow cells were injected as a positive control; 1 ml of HAYASHI ET AL.  1625 
RPMI  1640 was injected as a negative control. The macroscopically visible colonies were 
counted 10 d after the injection. 
GM-CFC Assay 
The in vitro colony-forming cell assay for rat and mouse myeloid progenitor cells (GM- 
CFC) was performed as described previously (17).  In the present study the agar medium 
was a mixture of 1 part 3% bacto-difco agar in 9 parts of McCoy's 5A medium supple- 
mented with 15% heat-inactivated rat serum or FBS, 0.015 M Hepes buffer, and 50 #g/ 
ml gentamycin sulfate (Schering Co.). 
Colony formation was  stimulated  by addition of 0.1  ml  of granuiocyte-macrophage 
colony-stimulating factor (GM-CSF) to each plate. GM-CSF was obtained from rat spleen 
conditioned medium (SCM) induced with pokeweed mitogen (17). Conditioned medium 
from cultures of rat TdT  + cells (TdT-CM) was also tested for GM-CSF activity. Culture 
medium was harvested on day 10 after seeding mouse bone marrow feeder layers with 
rat bone marrow cells from primary or long-term cultures. 
Autoradiography 
Cultured rat bone marrow cells were pulsed for 1 h with 1 #Ci per well of[~H]thymidine 
(New  England  Nuclear  Co.).  The  cells  were  washed,  smeared  on  glass  slides,  fixed, 
developed for TdT immunofluorescence, extracted with  5%  TCA, and processed for 
autoradiography as described previously (8). Slides treated with DNase (Sigma Chemical 
Co.) for 30 rain before TCA treatment served as controls. 
Characterization of TdT 
The structure, molecular weight, and specific activity of TdT in cell extracts was kindly 
determined by Dr. F.J.  Bollum (Uniformed Services University of the Health Sciences, 
Bethesda, MD) as described elsewhere (19). 
Leukemia Cells 
Two thymus-dependent, TdT  + leukemia cell types were used. G-1 leukemia cells (20) 
were a kind gift from the laboratory of Dr. R. Herberman, National Cancer Institute. V. 
I. L. leukemia ceils were obtained in our laboratory from the enlarged thymuses of adult 
rats infected neonatally with the rat-adapted Gross leukemia virus (4). 
Results 
Description  of the Culture System 
Feeder layer.  The ability of feeder layers prepared from mouse and rat bone 
marrow, spleen, and thymus to support the in vitro growth of TdT + cells from 
rat  and  mouse  bone  marrow  was  tested.  Only  a  xenogeneic  culture  system 
consisting  of a  mouse bone  marrow  feeder layer and  a  rat  bone marrow  cell 
suspension was able to consistently generate TdT + cells. The converse xenoge- 
neic combination and  the syngeneic combinations (rat-rat;  mouse-mouse) were 
ineffective. >99%  of the  TdT +  cells  that  appeared  in  the  mouse-rat  cultures 
were of rat origin, as determined by double immunofluorescence for TdT  and 
the appropriate rat and mouse major histocompatibility antigen (RT-1 and H-2, 
respectively). 
Bone marrow cells from 3-5-wk-old male C57BL/fJ, C57BL/10, A/J, A(Thy- 
1.1),  DBA/2J,  NZB,  NZW,  and  B6A  F1  strain  mice  were  equally  suitable  as 
feeder layers for bone marrow cell suspensions from LEW, DA, LDA FI, F344, 
M520, BUF, NIH-rnu (nu/nu, nu/+), ALB, and NBR strain rats. To standardize 
the system, bone marrow feeder layers from B6A F~ mice and bone marrow cell 1626  DESCRIPTION  OF  A  CULTURE  SYSTEM  FOR  TdT-POSITIVE  CELLS 
suspensions from LDA F] rats were used in the subsequent experiments, except 
as indicated. 
Serum supplement.  To optimally generate TdT ÷ cells in vitro it was necessary 
to supplement  the  tissue  culture  medium  with  20-30%  FBS.  However,  it  was 
noted that some lots of FBS were more supportive than others. 
Inasmuch as TdT ÷ cells are sensitive in vivo to the administration of adrenal 
glucocorticosteroid  hormones  and  to  PGE1  (21,  22), 2 we  suspected  that  the 
presence  of elevated  levels  of these  (and  possibly  other)  steroid  hormones  in 
some  lots  of FBS  might  inhibit  the  proliferation  of TdT-positive  cells  in  the 
culture system.  To test  this,  several  lots of FBS that only nominally supported 
the growth  of TdT ÷ cells  in  vitro were  extracted  with activated  charcoal  (Ch- 
XFBS),  which  has been  shown to selectively  remove steroid hormones (9,  23). 
After charcoal extraction, all lots of FBS strongly supported the growth of TdT + 
cells in vitro. 
One example of this effect  is shown in Fig.  1.  In cultures supplemented with 
30% unextracted FBS, the number of TdT + cells on day 10 was significantly less 
than  that  on  day  0  (Fig.  1A).  However,  in  cultures  supplemented  with  30% 
ChXFBS there was only a transient decline in TdT ÷ cells, which was followed by 
an exponential increase, so that the total number ofTdT + cells was approximately 
eightfold greater than starting levels by day 10 and 20-fold by day 14 (accounting 
for  30  and  75%  of total  nucleated  cells,  respectively)  (Fig.  1B).  Similarly  en- 
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Selective  growth  of LDA  F]  rat TdT + bone  marrow  cells  in  vitro  on  B6A  Ft 
mouse bone marrow feeder layers in medium supplemented with 30% (A) undefined FBS, (B) 
charcoal-extracted FBS, and (C) defined Hyclone FBS. Each point represents the mean +  SD 
of triplicate wells. (O) Total number  of nucleated cells/ml of culture (each well contained  2 
rid); (R) absolute number of rat TdT + cells/ml of culture. (D) Kinetics of generation of TdT + 
cells in long-term culture (also see Fig. 3). Note that only 5 ×  104 total nucleated cells/ml were 
inoculated into the cultures described in D. HAYASHI  ET  AL.  1627 
hanced growth of TdT ÷ cells was obtained with 30% defined HyClone FBS (Fig. 
1 C),  in  which  the  concentration  of total  hydrocortisone  (1.3  ng/ml)  was ~60 
times below that reported for normal rat plasma (24) and undefined FBS (25). 
Reconstitution  experiments  demonstrated  that,  among  a  variety  of steroid 
hormones,  only hydrocortisone  was able to  suppress  the  generation  of TdT  ÷ 
cells when added to the culture medium in concentrations at or below physiolog- 
ical levels (calculated as free cortisol, i.e., ~15% of total cortisol). Thus, cultures 
to which  1 ng/ml  hydrocortisone was added  on days 0,  2,  4,  and  6  contained 
10 times fewer TdT + cells on day 7 than  did untreated control cultures; and 
cultures that  received  10 ng/ml  hydrocortisone contained no detectable TdT ÷ 
cells. As shown in  Fig. 2B, dexamethasone had similar suppressive effects when 
used  at  10-fold  lower  concentrations.  PGE1  also  inhibited  the  generation  of 
TdT ÷ cells in vitro (Fig.  2C), but only when used at concentrations (500 ng/ml) 
~250 times greater than that present in the defined FBS (diluted 1:5 in medium). 
AIdosterone,  testosterone,  progesterone,  and estradiol  did not inhibit  the gen- 
eration of TdT + cells, even when used at concentrations approximately  1 x  103 
to 5 x  l04 times above those present in the defined FBS (Fig. 2D). 
Kinetics of  generation of TdT + cells in vitro.  The kinetics of generation ofTdT + 
cells in the primary cultures was linear with respect to time between days 3 ~nd 
14, after which the feeder layer began to deteriorate and the number of TdT ÷ 
cells decreased (Fig.  1, B and C). However, the generation  of TdT ÷ cells could 
be maintained  for more than  6 mo by serial passage of the nonadherent  cells in 
the  culture  to  fresh  feeder layers  at  10-d  intervals  (Fig.  3A).  Moreover,  the 
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FIGURE 2.  Effect of steroid hormones on the growth of rat TdT  + cells in vitro as compared 
to (A) untreated control cultures. The hormones were administered in the indicated doses on 
days 0, 2, 4, and 6. The cultures were harvested on day 7. (B) Dexamethasone; (C) prostaglan- 
din El (PGEI);  (D) estadiol 17/3 (E2~8), aldosterone (aldo),  progesterone (prog), and testosterone 
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FIGURE 3.  Long-term growth of LDA F, rat TdT  + bone marrow cells in vitro maintained 
by serial passage at 10-d intervals of nonadherent cells to fresh mouse bone marrow cell feeder 
layers in RPMI 1640 plus 30% defined FBS. (A) total TdT  + cells/ml generated after each 
transfer  between days 10 and  120. (B) TdT  + cells on days of transfer,  expressed as the 
percentage of total nucleated cells/ml of culture medium. The growth of the TdT  + cells in 
this culture has now been maintained for >10 too. 
percentage of TdT + cells progressively increased with time in culture, reaching 
a plateau of 75-80% by day 100 (Fig. 3B). 
The mean doubling time for the TdT + cells in primary culture (between day 
3  and  10) was  35.0  _+  9.58  h.  The  apparent  mean  doubling in  the  long-term 
cultures was 71.64 +_ 33.95 h  (Fig. 3A). However, closer inspection of the long- 
term cultures revealed a lag period of 2-3 d after each transfer (Fig.  1 D). If this 
lag is taken into account, the mean doubling time of TdT ÷ cells in the long-term 
cultures was 46.1  _+  12.9 h.  -20%  of the TdT ÷ cells in both the primary and 
long-term cultures incorporated [SH]thymidine during a 60-min pulse. 
The number of TdT ÷ cells that were generated in the primary cultures was 
directly proportional to the number of rat bone marrow cells that were initially 
added.  Results  in  Fig.  4  show  that  the  coefficient of linearity  (r 2)  was  0.97 
between doses of 10  s and  106 bone marrow cells. In long-term cultures there is 
a  similar  dose-response relationship between  the number of nonadherent  cells 
transferred  and  the  number  of TdT +  cells  generated  at  a  given  time  point. 
However, a plateau was reached in these cultures when approximately 5  x  105 
to 1 x  106 TdT + cells were generated (data not shown). Refeeding the cultures 
during  the  plateau  phase  did  not  cause  a  renewed  increase  in  the  growth  of 
TdT ÷ cells, whereas splitting and refeeding the cultures did. 
Fate of CFU-S and CFU-C.  As indicated in  Fig.  1 B, there was a  progressive 
decrease in the number of TdT-  cells in the cultures with time. By day 7, almost 
all of the nonlymphoid cells in the suspension were macrophages. Of these, 95% 
stained for mouse, but not rat, histocompatibility antigens,  indicating that they HAYASHI  ET  AL.  1629 
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FIGURE 4.  Dose-response relationship between the number of nucleated rat bone marrow 
cells added to the cultures at day 0 and the number of rat TdT  + cells present at day 10. 
TABLE l 
Presence of Rat CFU-S and GM-CFC in Cultures of Various Ages* 
Days of culture  CFU-S/I 0  6 cells  GM-CFC/10 5 cells 
0  15.6 ± 4.0  87.9 ± 8.8 
1  6.4 ±  1.5  ND 
3  5.9 ± 0.7  ND 
4  4.9 ±  1.6  ND 
6  0.3 ± 0.5  ND 
10  0.4 ±  1.3  31.7 ± 4.8 
148  0  ND 
195  ND  0 
316  ND  0 
* Results are expressed as the mean ± standard deviation of the number 
of in vivo (CFU-S) and in vitro (GM-CFC) colonies. Values of 0 indicate 
that no colonies were detected above control levels. ND, not determined. 
were derived from the feeder layer. Similarly, no rat origin myeloid or eythroid 
cells were identified in the long-term cultures. 
To determine whether CFU-S and GM-CFC survived or proliferated in these 
cultures,  the  nonadherent  cells were harvested at timed intervals and tested in 
the appropriate in vivo and in vitro assays. The results in Table I show that there 
was a  marked decrease in CFU-S and GM-CFC (presumably of rat origin) by day 
10;  and  that  neither  CFU-S  nor  GM-CFC  were  detectable  in  the  long-term 
cultures. 
Conditioned  medium (CM) from primary and long-term cultures of rat TdT + 
cells  was  tested  alone  or  mixed  with  SCM  in  the  GM-CFC  assay.  Neither 
stimulatory  nor  inhibitory  activity  was  identified  in  the  TdT-CM  (data  not 
shown). 1630  DESCRIPTION  OF  A  CULTURE  SYSTEM  FOR  TdT-POSITIVE  CELLS 
Factors stimulating TdT + cell growth.  Bovine pituitary fibroblast growth factor 
(FGF), guinea pig BMX (GP-BMX), and rat BMX (R-BMX) have been reported 
to stimulate the growth of cells of mesodermal origin, including hemopoietic 
cells (26, 27). 
When 1 ng/ml FGF was added to the medium on days 0, 2, 4, and 6, a twofold 
increase in the number ofTdT  + cells above levels in control cultures was observed 
on  day  7.  10  ng/ml FGF produced a  fourfold increase and  100  ng/ml FGF 
produced a  10-fold increase in the number of TdT  + cells. 
A threefold increase in the number of TdT  + cells in 7-d cultures was observed 
when  1 ug/ml GP-BMX was added to the medium on days 0,  2,  4, and 6.  A 
fourfold amplification was induced by 10 ~g/ml GP-BMX. Similar results were 
obtained with R-BMX (data not presented). However, mouse BMX (M-BMX), 
which has not been found to have mesodermalizing activity (26),  had no signifi- 
cant effect on the growth of TdT  + cells in vitro. 
A  mixture of 10  ng/mi FGF and  1 ~g/mi GP-BMX caused a  nearly  10-fold 
increase in the number of TdT  + cells above levels in control cultures. 
In addition to the preceding mesodermalizing factors, which required  30% 
ChXFBS to be maximally effective, a series of eight factors commonly found to 
reduce the serum requirements of cells in vitro (9) were tested (transferrin, 10 
~g/ml; nerve growth factor, 30 ng/ml; triiodothyronine, 1 x  10 -~l M; endothelial 
cell growth factor, 50 ~g/ml; gimmel factor,  10 ug/ml; selenium,  1 x  10 -9  M; 
LiCl,  1  X  10  -9  M;  and  Fe  SO4,  1  x  10 -~°  M).  Of these,  a  combination  of 
triiodothyronine (Ts), transferrin, and selenium permitted the concentration of 
ChXFBS to be reduced to 5%.  However, the addition of these three factors to 
cultures  containing  30%  ChXFBS  did  not  further  significantly increase  the 
generation of TdT  + cells. 
Properties of the TdT + Cells Generated In Vitro 
The properties of the TdT  + cells that were generated in vitro were compared 
with those of their in vivo counterparts in normal rat bone marrow and thymus. 
Without  exception,  the  cultured  TdT  ÷  cells  resembled  normal  TdT  ÷  bone 
marrow cells, but not thymocytes. 
Morphology.  The  immunofluorescence  pattern  of  TdT  staining  and  the 
mormphological appearance of the TdT  + cells  generated in vitro are shown in 
Figs.  5  and  6.  Like normal TdT  ÷ bone  marrow cells  and  unlike most TdT  + 
thymocytes (3,  15), the majority of cultured TdT  + cells were basophilic lympho- 
blasts that had a diffuse pattern ofintranuclear TdT fluorescence. As determined 
by FACS analysis and sorting (Fig. 7), the cultured TdT  + cells also had the same 
size  distribution  profile  as  did  normal  TdT  ÷  bone  marrow  cells,  which  are 
significantly larger than most TdT  + thymocytes. 
Antigenic phenotype.  Bone marrow cells from LDA F1, M520, and ALB strain 
rats were used to establish long-term cultures of TdT  + cells.  As shown in Table 
If, all of the TdT  + cells  from day  10 and day 70  cultures had the same "null" 
antigenic  phenotype as  did  noncultured TdT  + bone  marrow  cells.  All  were 
strongly positive for both the RT-I rat major histocompatibility antigen and the 
Thy-l.1 ailoantigen, the latter being expressed on immature bone marrow cells 
of all  lineages in the rat (17).  ~30%  of the day  10 TdT  + cells and 80%  of the -
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FIGURE 6.  Rat bone marrow cells in day-8 cultures stained for TdT by indirect immunoflu- 
orescence. ~35%  of the total  nucleated  cells in these samples were TdT  +, as indicated  by 
bright intranuclear fluorescence. These were medium-size lymphoblasts. Many  smaller lymph- 
oid cells  were TdT-. These appear as nonfluorescing "ghosts" in the photomicrograph (arrows). 
Scattered  monocytes and  macrophages  were  also present  (asterisks). See  Fig. 5B  for the 
different morphological cell types present. 
day  70  TdT + cells were positive for the  W3/13  antigen,  which,  in  addition  to 
being a  pan-T  cell antigen, is also present on many developing cells in rat bone 
marrow (11).  However,  in  contrast  to TdT ÷ thymocytes, none  of the  cultured 
TdT-positive  cells  displayed  T  cell-specific  differentiation  antigens;  and  in 
contrast  to  developing  B  cells,  none  had  detectable  surface  or  cytoplasmic 
immunoglobulin and none displayed Ia antigens. 
Properties of the  TdT.  As  in  vivo,  the  TdT  enzymatic  activity  in  vitro  was 
proportional to the percentage of TdT + cells present and the TdT  was a  single 
peptide chain of mol wt 58,000  (6,  19,  21). 
Leukemogenic Potential.  1  ×  105 or  1 x  106 TdT + cells from day  10 and day 
50 cultures  of either  Lewis or LDA  FI  rat bone marrow were injected  intrave- 
nously into  sublethally irradiated  (675  rad)  LDA F1  recipients.  Other recipient A 
HAYASHI  ET  AL.  1633 
NORMAL BONE MARROW 
B 
DAY 8  CULTURE 
C 
DAY  II  CULTURE 
D  NORMAL THYMUS 
FIGURE 7.  Forward angle light scatter profile determined by the FACS of (A) normal rat 
bone marrow; (B) day-8 cultured bone marrow cells, (C) day+-I 1 cultured bone marrow cells, 
and (D) normal rat thymocytes. 80% or more of the TdT  cells were located between the 
cursors in A and to the left of the cursors in B-D (see asterisks). The modal size distribution 
of the TdT  + cells in B and C, as determined by sorting on the FACS, is identical to that in A 
and significantly larger than that in D. 
rats were injected with allogeneic (G-1) or syngeneic (V. I. L.) TdT + rat leukemia 
cells or with media alone. As few as  1 ×  10 4 G-1  cells killed the recipient rats 
within 4  wk, and  1  ×  10 6 G-1  or V.  I.  L.  leukemic cells killed the recipients 
within 16 d (data not shown). At autopsy, all of the animals receiving either G- 1 
or V. I. L. cells had massive leukemic infiltrates in their tissues. In contrast, none 
of the recipients of the cultured TdT ÷ cells or media alone displayed gross or 
histoiogic evidence of leukemia when autopsied 8 wk after cell transfer. 
Discussion 
The  present  culture system is one of only two long-term  systems that have 
been reported to selectively generate primitive lymphoid cells in the absence of 
detectable CFU-S. Whitlock and Witte (28) and Kurland et al. (29) have described 
a  system that preferentially generates mouse pre-B  cells in  vitro.  Our  culture 
system preferentially generates undifferentiated rat TdT + cells, which we pos- 
tulate are early members of the T  cell lineage (see below). Both of these systems 1634  DESCRIPTION  OF  A  CULTURE  SYSTEM  FOR  TdT-POSITIVE  CELLS 
TABLE  II 
Antigenic Phenotype of Rat TdT + Cells* 
Antigens*  In vitro TdT  +  Normal  bone  marrow  TdT +  Thymic 
cells  0  TdT + cells 
cells 
RT- 1  ++  ++  ++ 
Thy  1.1  ++  ++  ++ 
W3/13  +  (++)  +  ++ 
OX-19  -  -  ++ 
W3/25  -  -  ++ 
OX-8  -  -  ++ 
OX-3,4  -  -  - 
RT-7 a (A.R.T.  1  a)  -  -  ++ 
RT-6 a (A.R.T.  2 a)  -  -  - 
A.R.T.  3 n  -  -  + 
clgM  -  -  - 
sIgM  -  -  - 
*  Determined  by double  immunofluorescence  for intranuclear  TdT  and 
surface  antigenic  markers.  (++)  76-100%  of TdT +  cells are  positive; 
(+) 1-75%  ofTdT  + cells are positive; (-) <  1% ofTdT  + cells are positive. 
See  Materials and  Methods  and  Results for description. 
0 Cells  analyzed  from  day  10  and  day  70  cultures.  Comparable  results 
were obtained,  excepting  W3/13,  in which approximately  30 and  80% 
of TdT ÷ cells were positive in day  10 and  day 70 cultures, respectively. 
I  Provisional designation. 
are modifications of the Dexter long-term culture system (30), which selectively 
maintains  CFU-S  and  GM-CFC  and  contains  only  low  levels  of presumptive 
lymphoid  precursor  cells  (8,  31,  32).  In  contrast  to  these  long-term  culture 
systems, Reimann and Miller (33) have described a short-term,  limiting dilution, 
microculture  system that apparently  permits the growth and differentiation  of 
cytolytic T  cells from Thy-1- precursors from nude mouse bone marrow. Several 
other culture systems have been described that generate colonies of differentiated 
T  or B cells in  semi-solid medium (34,  35).  However, these cultures appear to 
preferentially detect the progeny of relatively mature lymphocytes. 
A number of common features are shared by our lymphoid culture system and 
that  of Whitlock  and  Witte  (28),  including:  (a)  the  use  of FBS as  the  serum 
supplement;  (b)  the  need  for  reduced  levels  of  adrenal  glucocorticosteroid 
hormones;  (c)  the  presence  of adherent  monolayers of dispersed  mouse bone 
marrow  cells;  and  (d)  incubation  at  37°C.  In  contrast,  the  standard  Dexter 
culture system uses normal horse serum as the serum supplement, hydrocortisone 
frequently  is  added,  the  three-dimensional  orientation  of the  bone  marrow 
stroma is maintained in the feeder layer, and the cultures are incubated at 33°C 
(31, 36). 
These differences presumably account not only for the maintenance of lymph- 
oid precursor cells in our culture system, but for the inability of these cultures 
to support the growth of CFU-S and GM-CFC. For example, adrenal corticoste- 
roid hormones  have been  shown  to have profound lymphocytolytic effects on 
TdT + bone marrow cells and thymocytes and on immature  B lymphocytes (17, 
21, 23, 37, 38), but to improve myelopoiesis and prolong the survival of CFU-S HAYASH1ET  AL.  1635 
in vitro (28, 29, 36; and unpublished results). Hence subphysiological concentra- 
tions of adrenal  corticosteroids would be expected to favor the growth of early 
lymphoid cells as opposed to CFU-S and myeloid progenitor cells. Similarly, we 
have shown that pharmacological doses of PGE1  inhibit the production of TdT + 
bone marrow  cells and  thymocytes in  vivo (22); ~ and  that  a  concentration  of 
PGE~  (500  ng/ml)  roughly  equivalent  to that  normally present  in  the  thymus 
microenvironment (39) inhibits the generation of TdT  ÷ cells in vitro. Therefore, 
it is possible that the relative absence of myelopoiesis in our culture system, and 
the presumed decrease in monocyte-derived PGE~ (38), might further favor the 
outgrowth  of TdT ÷ cells.  Although  this  remains  to  be tested,  it  may help  to 
explain why in standard  Dexter cultures, which favor myelopoiesis, TdT + bone 
marrow cells are not generated at levels greater than those normally seen in vivo 
(~2%) (8).  That the reciprocal generation of lymphoid cells and myeloid cells is 
not restricted to the in vitro situation has recently been illustrated by Engelhard 
et al.  (40)  in  cases of cyclic neutropenia.  Thus,  our  results  suggest  that  both 
adrenal corticosteroids and PGEI may be involved in the complex feedback loops 
that  normally  regulate  the  relative  production  of lymphoid and  myeloid cells 
during hemopoiesis. 
A second requirement for the growth of rat bone marrow TdT  + cells in our 
culture system is the presence of a  mouse bone marrow  feeder layer.  Neither 
syngeneic, allogeneic, nor other xenogeneic feeder layers from bone marrow or 
other  tissues could be substituted.  Moreover,  the  mouse bone marrow  feeder 
layer  could  not  be  replaced  by  CM  from  the  feeder  layers  (unpublished). 
Therefore,  it seems that  the growth of TdT + cells is not caused simply by rat 
bone  marrow  lymphocytes reacting  against  xenogeneic  antigens  or  solely  by 
factors  released  by  the  feeder  layers.  Rather,  the  results  of ongoing  studies 
suggest that the physical adherence of even more primitive rat lymphoid precur- 
sor cells (pre-TdT + cells) to the feeder layer is necessary for the generation  of 
the nonadherent  TdT + cells. 3 For the moment, there is no obvious explanation 
as to why mouse bone marrow feeder layers do not also support the growth of 
mouse TdT ÷ cells or, conversely, why rat feeder layers do not support the growth 
of rat  TdT + cells.  However, it  has  been  noted  that  the adherent  cells grown 
from  rat  bone  marrow  significantly  differ  morphologically  from  those  grown 
from mouse bone marrow (unpublished results). 
By serially passaging the nonadherent  cells onto fresh feeder layers, we have 
managed  to  generate  TdT + cells  in  vitro  for  >10  mos.  These  cultured  cells 
appear to be indistinguishable  according to morphology, size, antigenic pheno- 
type, and cortisone sensitivity from their normal,  undifferentiated counterparts 
in bone marrow. They are generated with equal facility from the bone marrow 
of normal and congenitally athymic rats.  Moreover, they do not cause leukemia 
after injection into irradiated,  histocompatible recipients. 
It might be argued that the persistence of TdT + cells in our culture system is 
due to the selection of one or several lines of rapidly proliferating  TdT  + cells. 
This  seems  unlikely  for  several  reasons.  First,  there  is  a  strict  dose-response 
3 Medlock, E. S., D. L. Greiner, J. Hayashi, and I. Goldschneider. A selective culture system for 
generating terminal deoxynucleotidyl transferase-positive (TdT  ÷) lymphoid precursor cells in vitro. 
II. Properties of the lymphopoietic stem cells.  In preparation. 1636  DESCRIPTION  OF  A  CULTURE  SYSTEM  FOR  TdT-POSITIVE  CELLS 
relationship  between  the  number  of bone  marrow  cells  inoculated  and  the 
number of TdT + cells generated in the primary cultures.  Second, there is only 
a short lag phase between the time of initiation of the cultures and the logarithmic 
generation  of TdT  ÷ cells. This is particularly  true when the bone marrow cell 
inoculum is obtained from dexamethasone-treated donors, in which case no lag 
phase whatsoever is observed. 3 Third, the mean doubling time for the generation 
of TdT + cells is similar  in  both short-term  and  long-term  cultures,  indicating 
that no particular clone had a proliferative advantage over any other. 
Our working hypothesis, based on previously published evidence (1, 2,  16) is 
that  most of the TdT ÷ cells in our culture system are early members of the T 
cell lineage. Three additional pieces of evidence further support this assumption. 
First, we have not detected cytoplasmic Ig (or surface Ig) in any of the rat TdT  + 
cells generated in vitro. Second, the cultured TdT ÷ cells appear to bear a T-100 
antigen  (41)  that  is present  on  thymocytes and  peripheral  T  cells but not  on 
mature or immature B cells (unpublished). Third, bone marrow cells from 4-wk- 
old rats infected neonatally with the rat-adapted  Gross leukemia virus (4) selec- 
tively generate TdT ÷ leukemias of the helper/inducer T  cell phenotype (OX-8-, 
W3/25 +)  in  our  culture  system.  4  Nonetheless,  the  possibility  has  not  been 
excluded that some of the cultured rat TdT ÷ cells are primitive members of the 
B cell lineage. Such a possibility has been suggested by Whitlock and Witte (28), 
who found that  7 of 11  clones of Abelson virus-transformed  mouse pre-B cells 
in  their  culture  system  expressed  TdT.  However,  closer  examination  of this 
system has revealed that only 1 of 6 transformed pre-B cell lines was TdT  ÷ when 
the nontransformed  precursors were cloned before infection with the Abelson 
virus (42). Moreover, the TdT + clone appears to have originated from a precur- 
sor whose u heavy chain gene had not been rearranged. 
In  vivo adoptive transfer  studies and  in  vitro induction  studies,  currently  in 
progress, should help to clarify the lineage relationships of the cultured TdT  ÷ 
cells in our system. Whatever their developmental potential may prove to be, the 
ability to selectively generate TdT + cells in vitro offers a heretofore unavailable 
opportunity  to  study  the  very  early  stages  of normal,  as  well  as  abnormal, 
lymphopoiesis. One unique advantage of this culture system is that it permits the 
cellular  interactions  and  humoral  factors  that  influence  the  proliferation  of 
primitive  lymphoid  cells  to  be  distinguished  from  those  that  influence  their 
differentiation.  Another  advantage  of this  culture  system is  that  it  offers the 
opportunity  to conduct  the critical  cloning experiments  needed for studies of 
the  generation  of the  receptor  repertoire  and  the  induction  of self-tolerance. 
While  the  present  system  will  only  permit  such  analyses  to  be  done  on  rat 
iymphopoietic cells,  results of preliminary  experiments  suggest that  it  may be 
possible to adapt  this  xenogeneic culture  system to generate  mouse and,  ulti- 
mately, human  bone marrow TdT  ÷ cells in vitro, thereby further increasing its 
potential utility. 
4 Medlock, E. S.,  D.  L. Greiner, R.  W. Barton, and I. Goldschneider. A selective culture system 
for generating terminal deoxynucleotidyl transferase-positive (TdT ÷) lymphoid precursor cells in 
vitro. Ill. Generation of preleukemic and leukemic TdT  ÷ cells after infection with the rat-adapted 
Gross leukemia virus. In preparation. HAYASHI ET  AL.  1637 
Summary 
A  primary xenogeneic culture system has been devised that selectively gener- 
ates undifferentiated TdT ÷ lymphoblasts from rat bone marrow under conditions 
that  do  not  support  the  growth  or  maintenance  of rat  colony-forming unit- 
spleen (CFU-S) or granulocyte/macrophage colony-forming cells (GM-CFC). The 
culture system requires a mouse bone marrow feeder layer, and a serum supple- 
ment that has markedly reduced levels of cortisol. The growth of TdT ÷ cells can 
be significantly enhanced by the addition of mesodermalizing factors (e.g., fibro- 
blast growth  factor, guinea pig bone  marrow extract)  to the culture medium, 
and  the  serum  supplement  can  be  decreased  by  the  addition  of  selenium, 
transferrin, and T~, The cultured TdT + cells are antigenically "null" cells that 
further  resemble  their  normal  counterparts  in  bone  marrow  with  respect  to 
morphology, size, cortisone sensitivity, and pattern  of TdT  fluorescence.  The 
TdT + cells are generated with equal facility from bone marrow of normal and 
congenitally athymic rats, can be maintained in logarithmic growth for at least 
10 mos by serial passage in vitro, and do not cause leukemia when infused into 
irradiated  recipients.  Although  the  lineage  relationships  of  these  immature 
lymphoid cells have not yet been established, our working hypothesis, based on 
preliminary evidence, is that the cultured TdT + cells are primitive members of 
the T  cell series. 
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